Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
Medscape1d
Compounders Face Deadline to Stop Manufacturing Tirzepatide
The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...
The Hill19d
Ozempic and Wegovy officially moved off FDA’s drug shortage list
The FDA’s drug shortage list now states that as of Feb. 21 ... “We are pleased the FDA has declared that supply of the only real, FDA-approved semaglutide medicines is resolved, affirming ...
Chemistry World1d
Ending of US weight-loss drug shortages prompts compounder complaints
Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...
JD Supra13d
FDA Announces End to Semaglutide Shortage, Impacting Compounders and Telehealth Providers Offering Injectable GLP-1 Drugs
Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a ...
News Medical24d
Peptide Therapy: The Future of Targeted Treatment?
1 This growing area of pharmaceutical development led to 26 peptides being approved as drugs between 2016 and 2022 by the Food and Drug Administration (FDA), with more than 315 new drugs also ...
KOMU24d
FDA approves first drug to aid sleep apnea; drug also results in weight loss
Zepbound is the name of the first drug approved by the FDA for obstructive ... Zepbound works by activating GLP-1 (glucagon-like peptide-1), which regulates one's appetite, resulting in weight ...